Morphea (Localised Scleroderma): Symptoms, Causes and UK Online Doctor Advice

Morphea, also known as localised scleroderma, is an uncommon inflammatory skin condition. It leads to the development of firm, discoloured patches on various parts of the body. While the name 'scleroderma' can be alarming, it is important to distinguish morphea from systemic sclerosis. Systemic sclerosis can affect internal organs such as the lungs or heart; morphea, however, is generally confined to the skin and the tissues directly beneath it.

In the UK, morphea is considered a rare condition, often managed by dermatologists. The exact cause remains unknown, though it is widely categorised as an autoimmune-related disorder where the body's immune system triggers an overproduction of collagen. This excess collagen results in the characteristic thickening and hardening (sclerosis) of the skin seen in British patients.

The appearance of morphea changes over time, usually progressing through distinct stages. Because it is painless, many people in the UK do not notice the patches until they have already begun to harden. The symptoms typically include:

• Red or Purple Patches: Often the first sign, these are flat or slightly raised areas of skin that may feel itchy or tender.
• Hardened Skin: As the condition progresses, the centre of the patch becomes firm, shiny, and ivory-white or yellowish.
• The 'Lilac Ring': Active patches often have a faint violet or lilac-coloured border, indicating ongoing inflammation.
• Loss of Hair and Sweat Glands: In the affected area, hair follicles and sweat glands may be destroyed by the thickening collagen.
• Skin Thinning (Atrophy): Once the inflammation subsides, the skin may appear thinner or darker (hyperpigmented) than the surrounding area.

Morphea can appear anywhere, but it is most commonly found on the torso, arms, and legs. If it occurs over a joint, it may lead to stiffness or difficulty with movement.

NICE guidance and UK dermatological standards classify morphea based on how it is distributed across the body. Understanding the type helps determine the level of treatment required:

Plaque Morphea

This is the most common form in adults. Patients usually develop three or four oval-shaped patches, typically on the chest, stomach, or back.

Linear Morphea

More common in children, this type appears as a 'line' of thickened skin, often down an arm or leg. A specific subtype known as en coup de sabre occurs on the forehead or scalp and can sometimes affect the underlying bone or even neurological health.

Generalised Morphea

This involves more extensive patches that may merge together, covering larger areas of the body. This type requires more intensive systemic treatment to prevent widespread skin tightening.

Medical researchers have yet to identify a single cause for morphea, but several factors are believed to play a role. It is not contagious and cannot be passed from person to person. Potential triggers include:

• Autoimmune Response: The prevailing theory is that the immune system mistakenly attacks the skin's connective tissue.
• Environmental Triggers: Some cases in the UK have been reported following local trauma to the skin, radiation therapy, or certain infections (such as Lyme disease), although evidence for the latter is inconsistent.
• Genetic Predisposition: While not directly hereditary, there may be a genetic tendency toward autoimmune conditions in some families.

Morphea is most frequently diagnosed in women and is more common in the Caucasian population, though it can affect anyone at any age.

While there is currently no cure for morphea, the condition often 'burns out' and becomes inactive over several years. The goal of treatment is to control the inflammatory phase and prevent the patches from becoming larger or deeper. Common UK treatments include:

• Topical Treatments: High-potency corticosteroid creams or calcineurin inhibitors (like tacrolimus) are often used for superficial plaque morphea to reduce inflammation.
• Phototherapy (UVB/UVA1): Exposure to specific wavelengths of ultraviolet light can help soften the hardened skin and is commonly available in NHS dermatology departments.
• Systemic Medication: For linear or generalised morphea, medications that suppress the immune system, such as methotrexate or oral steroids, may be prescribed.
• Vitamin D Analogues: Creams containing substances like calcipotriol may be used to help improve skin texture.

Physiotherapy is also vital for patients where the skin tightening occurs over joints, ensuring that mobility is maintained during the sclerotic phase.

If you notice new, unexplained patches of discoloured or hard skin, you should seek medical advice. Speaking to an online doctor in the UK is a convenient first step for an initial assessment. An online GP can review your symptoms, examine the patches via high-quality photos or video consultation, and discuss your medical history.

Because morphea can resemble other skin conditions—such as lichen sclerosus or fungal infections—a professional opinion is necessary. If the online doctor suspects morphea, they can provide a private referral to a consultant dermatologist for more specialised tests, such as a skin biopsy, or advise you on the best pathway for an NHS referral. Early intervention is particularly critical for infants and children with linear symptoms to avoid growth complications.